Mayne Pharma Group Limited (ASX:MYX) Directors Insider Transactions
The Directors and Chief Executives of Mayne Pharma Group Limited (ASX:MYX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Mayne Pharma Group Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Mayne Pharma Group Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Mayne Pharma Group Limited Directors/Insider Transactions Activity
List of Insider trades activity from Mayne Pharma Group Limited (MYX).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 28 Feb 2026 | Blake (Patrick J) | Former | 22,097 | - | - |
| 18 Dec 2025 | O'Brien (Shawn Patrick) | Chief Executive Officer | 196,716 | - | - |
| 30 Jun 2025 | Gray (A) | Chief Financial Officer | 81,691 | - | - |
| 28 Feb 2025 | Robinson (Bruce Gregory) | Independent Non-Executive Director | 15,103 | - | - |
| 02 Sep 2024 | O'Brien (Shawn Patrick) | Chief Executive Officer | 23,816 | - | - |